Search results
GoodRx Holdings, Inc. (NASDAQ:GDRX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 5 days agoGoodRx Holdings, Inc. (NASDAQ:GDRX) Q1 2024 Earnings Call Transcript May 9, 2024 GoodRx Holdings,...
Earnings call: Clear Channel Outdoor sees revenue rise, digital growth By Investing.com
Investing.com· 6 days agoClear Channel Outdoor (NYSE:CCO) Holdings, Inc. (NYSE: CCO) reported a rise in revenue for the first...
Earnings call: Fennec Pharmaceuticals Q1 2024 results and updates By Investing.com
Investing.com· 1 day agoDespite facing marketplace challenges, particularly confusion over FDA safety messages and unlawful...
Cost and Valtoco: Financial assistance options, savings, more
Medical News Today· 2 days agoFor information about Valtoco, including Valtoco side effects, Valtoco dosage, and how to use the...
Camzyos and cost: Reducing long-term drug costs and more
Medical News Today· 2 days agoThe cost of the drug with and without insurance can depend on several factors, such as whether...
Limbach Holdings, Inc. (NASDAQ:LMB) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 5 days agoLimbach Holdings, Inc. (NASDAQ:LMB) Q1 2024 Earnings Call Transcript May 9, 2024 Limbach Holdings,...
Q1 2024 Limbach Holdings Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 6 days agoThey quickly turned to us develop a capital project funding plant under a sole source design-build arrangement, thereby gaining competitive advantages relative to the competition in the < ...
Earnings call: Fennec Pharmaceuticals Q1 2024 results and updates
Investing.com· 2 days agoDespite facing marketplace challenges, particularly confusion over FDA safety messages and unlawful...
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoCrinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Q1 2024 Earnings Call Transcript May 11, 2024...
Earnings call: Seres Therapeutics reports on Q1 2024 with VOWST updates By Investing.com
Investing.com· 2 days agoSeres Therapeutics (NASDAQ:MCRB), a biotechnology firm focused on microbiome therapeutics, has...